ARGEMOL TARRO CRA 28G RITUXIMAB PRINCIPIO ACTIVO: AZITROMICINA

Description

PRINCIPIO ACTIVO: AZITROMICINA

Cefalea o náuseas

Desarrollo de inhibidores (poco frecuente)

Desmopresina 15 mcg/mL

DUPIXENT® 200 mg es un medicamento de uso subcutáneo que contiene Dupilumab

ARGEMOL TARRO CRA 28G RITUXIMAB PRINCIPIO ACTIVO: AZITROMICINASULFADIAZINA DE PLATA 1. 00 %

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy